K Prabhash Selected Research

Microtubule-Associated Proteins (Microtubule-Associated Protein 2)

1/2015	Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung.
4/2013	A year of anaplastic large cell kinase testing for lung carcinoma: pathological and technical perspectives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K Prabhash Research Topics

Disease

31	Neoplasms (Cancer) 03/2024 - 01/2006
14	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023 - 12/2010
10	Lung Neoplasms (Lung Cancer) 12/2023 - 11/2014
8	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020 - 01/2013
6	Carcinoma (Carcinomatosis) 01/2019 - 01/2013
6	Renal Cell Carcinoma (Grawitz Tumor) 10/2016 - 07/2013
5	Infections 12/2023 - 10/2009
2	Neoplasm Metastasis (Metastasis) 01/2023 - 10/2014
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 01/2019
2	Esophageal Neoplasms (Esophageal Cancer) 10/2022 - 04/2013
2	Squamous Cell Carcinoma of Head and Neck 01/2021 - 09/2016
2	Brain Neoplasms (Brain Tumor) 01/2018 - 12/2010
2	Adenocarcinoma 01/2018 - 07/2015
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2017 - 04/2013
2	Adenocarcinoma of Lung 01/2017 - 01/2015
2	Disease Progression 09/2016 - 07/2013
2	Exanthema (Rash) 07/2016 - 01/2016
2	Febrile Neutropenia 04/2016 - 10/2014
2	Mouth Neoplasms (Oral Cancer) 12/2015 - 04/2013
2	Leukemia 01/2011 - 01/2009
2	Acute Promyelocytic Leukemia 01/2011 - 01/2009
2	Lymphoma (Lymphomas) 07/2008 - 07/2007
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2008 - 07/2007
1	Malignant Teratocarcinosarcoma 03/2024
1	Esophageal Squamous Cell Carcinoma 10/2022
1	Seminoma 01/2021
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 12/2019
1	Nasopharyngeal Carcinoma 12/2019
1	Sensorineural Hearing Loss 04/2017
1	Thoracic Diseases 01/2017
1	Pneumonia (Pneumonitis) 01/2017
1	Mucositis 07/2016
1	Vomiting 07/2016
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2016
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 04/2016
1	Diarrhea 01/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2016
1	Pulmonary Atelectasis 07/2015
1	Hematologic Neoplasms (Hematological Malignancy) 10/2014
1	Peripheral Nervous System Diseases (PNS Diseases) 07/2014
1	Prostatic Neoplasms (Prostate Cancer) 07/2014

Drug/Important Bio-Agent (IBA)

7	ErbB Receptors (EGF Receptor)IBA 12/2023 - 04/2013
7	Tyrosine Kinase InhibitorsIBA 01/2017 - 07/2013
4	PlatinumIBA 01/2021 - 04/2013
4	Cisplatin (Platino)FDA LinkGeneric 04/2017 - 01/2016
4	Anaplastic Lymphoma KinaseIBA 01/2017 - 04/2013
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2017 - 04/2013
4	Docetaxel (Taxotere)FDA Link 09/2016 - 02/2004
3	Imatinib Mesylate (Gleevec)FDA Link 01/2016 - 07/2005
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2014 - 10/2009
2	NivolumabIBA 01/2021 - 01/2017
2	taxaneIBA 12/2019 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 12/2017 - 01/2015
2	CrizotinibIBA 04/2017 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2017 - 04/2013
2	Sunitinib (Sutent)FDA Link 01/2016 - 07/2013
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2015 - 04/2013
2	Retinoic Acid Receptor alphaIBA 01/2011 - 01/2009
2	Ceftazidime (Fortum)FDA LinkGeneric 04/2010 - 10/2009
2	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 04/2010 - 10/2009
1	nimotuzumabIBA 01/2020
1	Pemetrexed (MTA)FDA Link 01/2018
1	QuartzIBA 01/2018
1	CreatinineIBA 04/2017
1	Carboplatin (JM8)FDA LinkGeneric 04/2017
1	Formaldehyde (Formol)FDA Link 01/2017
1	ParaffinIBA 01/2017
1	Celecoxib (Celebrex)FDA Link 01/2017
1	ceritinibIBA 01/2017
1	Methotrexate (Mexate)FDA LinkGeneric 01/2017
1	Cetuximab (Erbitux)FDA Link 01/2017
1	pazopanib FDA Link 10/2016
1	GoldIBA 10/2016
1	AntiemeticsIBA 07/2016
1	Sorafenib (BAY 43-9006)FDA Link 07/2016
1	CytokinesIBA 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2015
1	Gefitinib (Iressa)FDA Link 10/2015
1	Fluorouracil (Carac)FDA LinkGeneric 01/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2015
1	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2014
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 10/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2014
1	Hemoglobins (Hemoglobin)IBA 10/2014
1	cabazitaxel FDA Link 07/2014

Therapy/Procedure

22	Drug Therapy (Chemotherapy) 03/2024 - 07/2007
21	Therapeutics 12/2023 - 07/2007
9	Radiotherapy 01/2024 - 12/2010
8	Neoadjuvant Therapy 03/2024 - 01/2013
6	Induction Chemotherapy 12/2019 - 01/2013
3	Chemoradiotherapy 10/2022 - 07/2015
2	Adjuvant Radiotherapy 01/2024 - 01/2023
1	Cystectomy 01/2023
1	Image-Guided Radiotherapy 01/2022
1	Immunotherapy 01/2021
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2021
1	Aftercare (After-Treatment) 01/2018
1	Palliative Care (Palliative Therapy) 10/2015
1	Tracheostomy 04/2014